PortfoliosStock ScreensStocksStockXcel

XTL Biopharmaceuticals Ltd

XTLB | US

2.29

USD

-0.11

-4.58%

XTLB | US

About XTL Biopharmaceuticals Ltd

Sector

Healthcare

Industry

Biotechnology

Earnings date

31/03/2024

As of date

02/06/2026

Close

2.29

Open

2.42

High

2.42

Low

2.26

XTL Biopharmaceuticals Ltd. a biopharmaceutical company engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1 a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research development and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan Israel.

View Less

XTLB | US

Risk
100.5
Sharpe
0.23
Luna's Score
34/100
Recommendation
Sell

Luna says (XTLB | US)

What's Working
What's not Working

Negative Momentum (Declining Price)

Price Below SMA10D

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

49.2%

1 month

100.5%

3 months

705.0%

6 months

515.2%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

4.37

Debt to equity

-

Debt to assets

-

Ent. to EBITDA

16.54

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-764.00K

MarketCap

12.48M

MarketCap(USD)

12.48M

Div. yield

-

Op. margin

-

Erngs. growth

-76.00

Rev. growth

-

Ret. on equity

-13.07

Short ratio

2.30

Short perc.

1.02

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bullish (SMA1M > SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

0.43

Range1M

1.76

Range3M

4.31

Volumes: Market Activity

Rel. volume

0.13

Price X volume

17.80K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
CytoMed Therapeutics Limited Ordinary SharesGDTCBiotechnology1.1413.16M-0.10%n/a3.98%
Kezar Life Sciences IncKZRBiotechnology0.1813.13M5.88%n/a11.69%
Kala Pharmaceuticals IncKALABiotechnology2.3913.10M8.64%n/a268.29%
PLURPLURBiotechnology2.36512.94M-1.87%n/a30845.83%
Aytu BioScience IncAYTUBiotechnology2.112.91M-2.33%n/a54.59%
Marker Therapeutics IncMRKRBiotechnology1.4212.67M-6.58%n/a0.00%
Cingulate Inc. Common StockCINGBiotechnology4.0312.27M11.94%n/a10.72%
Lipocine IncLPCNDrug Manufacturers-Specialty & Generic2.2512.03M-1.32%n/a0.00%
Longeveron Inc. Class A Common StockLGVNBiotechnology0.7610.91M-1.30%n/a11.72%
HOOKIPA Pharma IncHOOKBiotechnology1.0910.79M-4.39%n/a5.69%

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.42758.26M-0.47%n/a58.43%
EZGO Technologies Ltd. Ordinary SharesEZGORecreational Vehicles1.714.37M1.18%n/a17.32%
Micromobility.com Inc.MCOMRecreational Vehicles0.0063580.95K12.50%n/a-37.05%
Vision Marine Technologies IncVMARRecreational Vehicles0.4821265.64K-11.54%n/a0.00%

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA16.54-Expensive
Ent. to Revenue---
PE Ratio-41.03-
Price to Book4.3715.55Cheaper
Dividend Yield---
Std. Deviation (3M)704.97-Riskier
Debt to Equity--1.23-
Debt to Assets-0.25-
Market Cap12.48M-Emerging

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007